Vaginal and Vulvar Tumors 

Description – Vaginal and vulvar tumors are the second most common canine female reproductive tumor after those of the mammary gland. They constitute 2.4% to 3% of canine neoplasia. Unlike mammary gland tumors, vaginal lesions are non-cancerous in nature and originate from the smooth muscle tissues (involuntary muscle found in arteries, veins, bladder and uterus).

Non-malignant vaginal and vulvar tumors reported in the veterinary literature are leiomyomas, fibroleiomyomas, fibromas, polyps, lipomas, sebaceous adenomas, fibrous histiocytomas, benign melanomas, myxomas and myxofibromas. There have been reports of malignant tumors as well like transmissible venereal tumors (TMTs), adenocarcinoma, squamous cell carcinoma, hemangiosarcoma, osteosarcoma, mast cell tumor and epidermoid carcinoma.

Unspayed, nulliparous (never having given birth to a pup) dogs in the age group of 2-18 years are more susceptible. However, lipomas tend to occur in younger dogs in the age group of 1 to 8 years are susceptible to lipomas. In one study Boxers were over represented.

Leimyomas mostly originate from the vestibule of the vulva (a triangular space between the nymphae, in which the orifice of the urethra is situated). They manifest themselves both as extraluminal and intraluminal forms. The extraluminal ones are slow growing tumors that appear gray, white or tan. They are well differentiated and poorly vascularized (supply tissues with blood vessels). The intraluminal tumors on the other hand are found on the vaginal wall. They are firm and ovoid. Sometimes there is ulceration due to exposure, irritation or secondary infection.

Symptoms – The clinical signs not commonly seen may include vulvar bleeding or discharge, an enlarged vulvar mass, dysuria (painful urination), hematuria (blood in the urine), tenesmus (difficulty in defecating), excessive vulvar licking and dystocia (abnormal difficulty in childbirth or labor). Tumors that lack pedunculation (the stalk like base to which a polyp or tumor is attached) and tend to occur frequently in the vaginal and vulvar region eventually progress to malignancy.

Diagnostic techniques and work-ups – The diagnostic techniques may include vaginoscopic examination, retrograde vaginography, or urethrocystography, aspiration cytology, caudal abdominal radiographs, ultrasonography and advanced imaging like magnetic resonance imaging and computed tomography.

Treatment – Since it has been found that vaginal tumors are hormone dependant, ovarihysterectomy is the treatment of choice. This also allows examination of the abdominal organs for the presence of metastasis. Conservative surgical extirpation combined with ovarihysterectomy results in complete remission of the benign tumors. The ones found on the vaginal wall can be removed by transfixing sutures in the pedicle. Sometimes due to the poor visibility of pedicle or urethral papilla (the slight projection in the vestibule of the vagina marking the urethral orifice), ovarihysterectomy becomes difficult. To make things simpler and easier a dorsal episiotomy (an incision made through the perineum to assist childbirth) is performed. It also assists in the surgical extirpation of extraluminal tumors.

However, if the primary tumor and secondary tumors cannot be removed completely, vets take recourse to radiation therapy.

For malignant vaginal tumors, complete vulvovaginectomy and perineal urethrestomy are performed.

Prognosis – The prognosis for benign vaginal and vulvar tumors is quite good. However, the outcome for adenocarcinomas and squamous cell carcinomas is generally guarded.

Thank you for utilizing our Canine Cancer Library. Please help us keep this ever evolving resource as current and informative as possible with a donation.

Reference

Withrow and MacEwen’s Small Animal Clinical Oncology – Stephen J. Withrow, DVM, DACVIM (Oncology), Director, Animal Cancer Center Stuart Chair In Oncology, University Distinguished Professor, Colorado State University Fort Collins, Colorado; David M. Vail, DVM, DACVIM (Oncology), Professor of Oncology, Director of Clinical Research, School of Veterinary Medicine University of Wisconsin-Madison Madison, Wisconsin